Granite Point Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Granite Point Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,760	Closed	-$3.57M	–	108
2015 Q2	$3.57M	Sell	3,760 -203	-5%	-$166K	1.04%	8
2015 Q1	$2.9M	Buy	3,963 +2,213	+126%	+$1.66M	1.06%	16
2014 Q4	$1.39M	Sell	1,750 -250	-13%	-$135K	0.65%	27
2014 Q3	$798K	Buy	+2,000	New	+$536K	0.4%	48

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Granite Point Capital Management's TTPH Position: Q3 2015 in Review

Granite Point Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 3,760 shares — an estimated $3.57M sold.

Granite Point Capital Management first reported a position in TTPH in Q3 2014 and held it in 4 quarters. The position peaked at $3.57M in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

Granite Point Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Granite Point Capital Management sold 3,760 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $3.57M.
Granite Point Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
Granite Point Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $3.57M in Q2 2015.
105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on Granite Point Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.